The need for reliable serum parathyroid hormone measurements

Kidney International

Volumn 70, Issue 2, 2006, Pages 240-243

  Torres, P Urẽa ^a  

^a Clinique de l'Orangerie Aubervilliers   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID DERIVATIVE; ARGININE; CALCIMIMETIC AGENT; GLIAL CELL MISSING TRANSCRIPTION FACTOR; LYSINE; PARATHYROID HORMONE; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG;

AMINO TERMINAL SEQUENCE; BONE BIOPSY; BONE REMODELING; BONE TURNOVER; CARBOXY TERMINAL SEQUENCE; CATABOLISM; CHROMOSOME SIZE; CHRONIC KIDNEY DISEASE; ENDOCYTOSIS; EXON; GENE; GLOMERULUS FILTRATION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HYPERCALCEMIA; HYPERPARATHYROIDISM; MORPHOMETRICS; PARATHYROID CARCINOMA; PARATHYROID GLAND; PARATHYROID HORMONE BLOOD LEVEL; PARATHYROIDECTOMY; PRIORITY JOURNAL; RADIOIMMUNOASSAY; RENAL OSTEODYSTROPHY; REVIEW;

EID: 33746157757     PISSN: 00852538     EISSN: 15231755     Source Type: Journal    
DOI: 10.1038/sj.ki.5001658     Document Type: Note

References (26)

1. Hindié E, Ureña P, Jeanguillaume C et al. Preoperative imaging of parathyroid glands with 99m-labelled sestamibi and iodine-123 subtraction scanning in secondary hyperparathyroidism. Lancet 1999; 2: 2200-2204.
2. Günther T, Chen Z, Kim J et al. Genetic ablation of parathyroid glands reveals another source of parathyroid hormone. Nature 2000; 406: 199-203.
3. Hendy GN, Kronenberg HM, Potts JT Jr, Rich A. Nucleotide sequence of cloned cDNAs encoding human preproparathyroid hormone. Proc Natl Acad Sci USA 1981; 78: 7365-7369.
4. D'Amour P, Räkel A, Brossard JH et al. Acute regulation of circulating parathyroid hormone (PTH) molecular forms by calcium: utility of PTH fragments/PTH (1-84) ratios derived from three generations of PTH assays. J Clin Endocrinol Metab 2006; 91: 283-289.
5. Habener JF, Mayer GP, Dee PC, Potts JT Jr. Metabolism of amino- and carboxyl-sequence immunoreactive parathyroid hormone in the bovine: evidence for peripheral cleavage of the hormone. Metabolism 1976; 25: 385-395.
6. Murray TM, Rao LG, Divieti P, Bringhurst FR. Parathyroid hormone secretion and action: evidence for discrete receptors for the carboxyl-terminal region and related biological actions of carboxyl-terminal ligands. Endocr Rev 2005; 26: 78-113.
7. Hilpert J, Nikjaer A, Jacobsen C et al. Megaline antagonizes activation of the parathyroid hormone receptor. J Biol Chem 1999; 274: 5620-5625.
8. Rouleau MF, Warshawsky H, Goldzman D. Parathyroid hormone binding in vivo to renal, hepatic, and skeletal tissues of the rat using a adioautographic approach. Endocrinology 1986; 118: 919-931.
9. deVernejoul MC, Kuntz D, Miravet L et al. Bone histomorphometry in hemodialysed patients. Metab Bone Dis Relat Res 1981; 3: 175-179.
10. Berson SA, Yalow RS. Immunochemical heterogeneity of parathyroid hormone in plasma. J Clin Endocrinol Metab 1968; 28: 1037-1047.
11. Nussbaum S, Zahradnik R, Lavigne J et al. Highly sensitive two-site immunoradiometric assay of parathyrin, and its clinical utility in evaluating patients with hypercalcemia. Clin Chem 1987; 33: 1364-1367.
12. Brossard J, Cloutier M, Roy L et al. Accumulation of a non-(1-84) molecular form of parathyroid hormone (PTH) detected by intact PTH assay in renal failure: importance in the interpretation of PTH values. J Clin Endocrinol Metab 1996; 81: 3923-3929.
13. Murray TM, Rao LG, Muzaffar SA, Ly H. Human parathyroid hormone carboxyterminal peptide (53-84) stimulates alkaline phosphatase activity in dexamethasone-treated rat osteosarcoma cells in vitro. Endocrinology 1989; 124: 1097-1099.
14. Kaji H, Sugimoto T, Kanatani M et al. Carboxy-terminal parathyroid hormone fragments stimulate osteoclastic-like cell formation and osteoclastic activity. Endocrinology 1994; 134: 1897-1904.
15. D'Amour P, Brossard JH, Rousseau L et al. Aminoterminal form of parathyroid hormone (PTH) with immunologic similarities to hPTH (1-84) is overproduced in primary and secondary hyperparathyroidism. Clin Chem 2003; 49: 2037-2044.
16. Gao P, Scheibel S, D'Amour P et al. Development of a novel immunoradiometric assay exclusivelyfor biologically active whole parathyroid hormone 1-84: implication for improvement of accurate assessment of parathyroid function. J Bone Miner Res 2001; 16: 605-614.
17. John M, Goodman W, Gao P et al. A novel immunoradiometric assay detects full-length human PTH but not amino-terminally truncated fragments: implicationsfor PTH measurements in renal failure. J Clin Endocrinol Metab 1999; 84: 4287-4290.
18. Slatopolsky E, Finch J, Clay P et al. A novel mechanism for skeletal resistance in uremia. Kidney Int 2000; 58: 753-761.
19. Monier-Faugère MC, Geng Z, Mawad H et al. Improved assessment of bone turnover by the PTH (1-84)/C-PTH fragments ratio in ESRD patients. Kidney Int 2001; 60: 460-468.
20. Reichel H, Esser A, Roth HJ, Schmidt-Gayk H. Influence of PTH assay methodology on differential diagnosis of renal bone disease. Nephrol Dial Transplant 2003; 18: 759-768.
21. Souberbielle J-C, Boutten A, Carlier M-C et al. Inter-method variability in PTH measurement: implication for the care of CKD patients. Kidney Int 2006; 70: 345-350.
22. Foley RN, Li S, Liu J et al. The fall and rise of parathyroidectomy in U.S. hemodialysis patients, 1992 to 2002. J Am Soc Nephrol 2005; 16: 210-218.
23. Ureña P, Kubrusly M, Mannstadt M et al. The renal PTH/PTHrP receptor is down-regulated in rats with chronic renal failure. Kidney Int 1994; 45: 605-611.
24. Ureña P, Ferreira A, Morieux C et al. PTH/PTHrP receptor mRNA is down-regulated in epiphyseal cartilage growth plate of uraemic rats. Nephrol Dial Transplant 1996; 11: 2008-2016.
25. Ureña P, Ferreira A, Kung V et al. Serum pyridinoline as a specific marker of collagen breakdown and bone metabolism in hemodialysis patients. J Bone Miner Res 1995; 10: 932-939.
26. Ureña P, Hruby M, Ferreira A et al. Plasma total versus bone alkaline phosphatase as marker of bone turnover in hemodialysis patients. J Am Soc Nephrol 1996; 7: 506-512.